CYTOKINETICS INC (CYTK) › Operating IncomeCYTOKINETICS INC (CYTK) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: $26.09M2010: -$49.63M2011: -$47.96M2012: -$40.46M2013: -$33.89M2014: -$14.75M2015: -$37.41M2016: $18.69M2017: -$113.40M2018: -$88.92M2019: -$98.87M2020: -$93.94M2021: -$186.31M2022: -$324.20M2023: -$496.20M2024: -$536.25M2025: -$612.26M-$612.26M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$612.26M-14.2%2024-$536.25M-8.1%2023-$496.20M-53.1%2022-$324.20M-74.0%2021-$186.31M-98.3%2020-$93.94M+5.0%2019-$98.87M-11.2%2018-$88.92M+21.6%2017-$113.40M-706.8%2016$18.69M+150.0%2015-$37.41M-153.5%2014-$14.75M+56.5%2013-$33.89M+16.2%2012-$40.46M+15.7%2011-$47.96M+3.4%2010-$49.63M-290.2%2009$26.09M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share